Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Sunshine Biopharma (SBFM) over the last 11 years, with Sep 2025 value amounting to -$36,168.

  • Sunshine Biopharma's Other Working Capital Changes rose 56.81% to -$36,168 in Q3 2025 from the same period last year, while for Sep 2025 it was $166,842, marking a year-over-year increase of 841.07%. This contributed to the annual value of $207,167 for FY2024, which is 879.84% up from last year.
  • Sunshine Biopharma's Other Working Capital Changes amounted to -$36,168 in Q3 2025, which was up 68.72% from -$115,617 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Other Working Capital Changes registered a high of $568,981 during Q1 2024, and its lowest value of -$736,637 during Q2 2024.
  • Over the past 3 years, Sunshine Biopharma's median Other Working Capital Changes value was -$65,125 (recorded in 2023), while the average stood at -$5,764.
  • In the last 5 years, Sunshine Biopharma's Other Working Capital Changes skyrocketed by 1,148.48% in 2021 and then plummeted by 1,860.45% in 2022.
  • Over the past 5 years, Sunshine Biopharma's Other Working Capital Changes (Quarterly) stood at $4,579 in 2021, then tumbled by 1,860.45% to -$80,611 in 2022, then surged by 433.85% to $269,120 in 2023, then skyrocketed by 70.39% to $458,558 in 2024, then soared by 56.81% to -$36,168 in 2025.
  • Its Other Working Capital Changes stands at -$36,168 for Q3 2025, versus -$115,617 for Q2 2025 and -$139,931 for Q1 2025.